# OnCo record hanmi-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hanmi-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hanmi-pharmaceutical" ;
  schema:name "Hanmi Pharmaceutical"@en ;
  schema:alternateName "Hanmi Pharm"@en, "한미약품"@en, "KRX:128940"@en ;
  schema:description "Hanmi Pharmaceutical is one of South Korea's largest drug companies, known for its long-acting protein platform and for olmutinib, the third-generation EGFR inhibitor approved in Korea as Olita in 2016."@en ;
  schema:url <https://onco.cc/companies/hanmi-pharmaceutical/>, <https://www.hanmipharm.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.hanmipharm.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "KR" ;
  onco:drugs <https://onco.cc/drugs/olmutinib/> .